Cargando…
Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System
Nucleic acid amplification testing (NAAT) for SARS-CoV-2 is the standard approach for confirming COVID-19 cases. This study compared results between two emergency use authorization (EUA) NAATs, with two additional EUA NAATs utilized for discrepant testing. The limits of detection (LOD) for the BD SA...
Autores principales: | Yanson, Karen, Laviers, William, Neely, Lori, Lockamy, Elizabeth, Castillo-Hernandez, Luis Carlos, Oldfied, Christopher, Ackerman, Ronald, Ackerman, Jamie, Ortiz, Daniel A., Pacheco, Sixto, Simner, Patricia J., Young, Stephen, McElvania, Erin, Cooper, Charles K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601249/ https://www.ncbi.nlm.nih.gov/pubmed/34586894 http://dx.doi.org/10.1128/JCM.01019-21 |
Ejemplares similares
-
Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAX(TM) System in asymptomatic individuals
por: Yanson, Karen, et al.
Publicado: (2023) -
Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric Pathogens
por: Stokes, William, et al.
Publicado: (2019) -
Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system
por: Paradis, Sonia, et al.
Publicado: (2021) -
Evaluation of the FecalSwab for Stool Specimen Storage and Molecular Detection of Enteropathogens on the BD Max System
por: Richard-Greenblatt, Melissa, et al.
Publicado: (2020) -
Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test
por: Young, Stephen, et al.
Publicado: (2020)